GlassScriptPhysician profile
Jenna Connolly
NPI 1710676879
$904.59
in general payments reported to CMS, 2019-2025
16 companies · $275 in 2025
The $275 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $267 · 2024: $363 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $904.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $178.01 | 2024-2025 | Adstiladrin |
| Abbvie INC. | $126.55 | 2023-2024 | |
| Janssen Biotech, INC. | $104.52 | 2023-2025 | Erleada |
| Boston Scientific Corporation | $63.10 | 2023-2025 | Ams 700, Spaceoar Vue System - 10ml |
| Antares Pharma, INC. | $55.14 | 2024-2025 | Xyosted |
| Endo USA, INC. | $53.81 | 2024-2025 | Xiaflex |
| Myriad Genetic Laboratories, INC. | $53.44 | 2024 | Prolaris |
| Sumitomo Pharma America, INC. | $47.15 | 2023 | Gemtesa |
| Karl Storz Endoscopy-America | $40.00 | 2023 | |
| Tolmar, INC. | $39.81 | 2023-2025 | Jatenzo, Eligard |
| Merck Sharp & Dohme LLC | $33.62 | 2024 | Keytruda |
| Immunitybio, INC. | $24.97 | 2025 | |
| Blue Earth Diagnostics | $23.93 | 2024 | |
| Calyxo, INC. | $21.16 | 2025 | Cvac Aspiration System |
| Endo Pharmaceuticals INC. | $20.73 | 2023 | Xiaflex |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $18.65 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Connolly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.